Precipio Announces ICEme Kit for Lung Cancer Mutation Detection
Earlier this year, Medgadget heard from Precipio CEO Illan Danieli on how his company uses advanced diagnostics and personalized medicine to reduce the prevalence of cancer misdiagnosis. Over 1 million patients globally and about 200,000 patients i...
Source: Medgadget - Category: Medical Devices Authors: Michael Batista Tags: Diagnostics Oncology Pathology Thoracic Surgery Source Type: blogs
More News: Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Lung Cancer | Men | Non-Small Cell Lung Cancer | Pathology | Study